According to Kristen Marie Kelly, MD, chair and professor of dermatology at the School of Medicine, energy-based devices remain a cornerstone of treatment, but there are emerging strategies that involve combining them with targeted medications. … She explained a deeper understanding of the genetic mutations underlying vascular malformations is paving the way for innovative approaches. 'Our treatments have improved, but for resistant lesions, there is hope for the future,' she said.
↧